Overview

Amanda Hollis is an intellectual property litigator and partner in Kirkland’s Chicago office. Amanda has tried and led patent cases in federal courts across the country and in the United States International Trade Commission. She also has served as lead counsel in many inter partes reviews before the United States Patent and Trademark Office’s Patent Trial and Appeal Board. Her practice includes all areas of technology, including biotechnology, medical devices, chemistry, computing and electronics, and her clients have included some of the nation’s largest companies, such as Abbott Laboratories, Pfizer, Baxter, Teva, C.R. Bard, IBM, Samsung and Cisco, among others.

Amanda has a track record of obtaining successful results for her clients. Recently, after taking over for another law firm, Amanda successfully led the defense for a large diagnostics company in a patent infringement and breach of contract suit. A California federal jury issued a verdict of non-infringement, a complete victory for Amanda’s client. In another complete victory, Amanda won a case for multinational medical device leaders in which their longtime business competitor claimed infringement of patents on stent graft devices used to treat damaged or blocked blood vessels. A Delaware federal jury concluded that Amanda’s client’s devices did not infringe and that the patent was invalid, including for improper inventorship, a defense that is rarely successfully pursued in patent trials. In another case in which hundreds of millions of dollars were potentially at stake, Amanda won summary judgment that all of the asserted patent claims were invalid. Meanwhile, other companies represented by other lawyers settled by paying the patent holder tens of millions of dollars. Amanda also served as lead counsel for one of the world’s largest biopharmaceutical companies in its high stakes inter partes review challenges to patents held out as protecting HERCEPTIN®, one of the best-selling drugs in the world. The case settled after Amanda succeeded in invalidating all claims of two of the challenged patents.

Amanda has been recognized by Chambers USA in the area of Intellectual Property, with comments that she “is a talented lead patent litigator who is well-regarded by judges and juries alike. She listens to her clients and works tirelessly and efficiently to meet their needs." Amanda has also been named to Benchmark Litigation’s 2016–2019 “Under 40 Hot List,” Law360’s 2018 “Top Attorneys Under 40” for Intellectual Property, and Best Lawyers 2017 “Women of Influence” list. Amanda also was recognized for Patent Litigation in The Legal 500 U.S., 2017–2022 and was recommended in the 2020–2023 editions of the IAM Patent 1000 - The World’s Leading Patent Professionals.

Along with representatives from Duff & Phelps, Archer Daniels Midland, Northwestern University and others, Amanda is a co-founder of Big Careers Little Kids (BCLK), a group connecting Chicagoland’s elite female professionals in the fields of law, finance and business.

More

Thought Leadership

Press Mentions

"FDA's Eva Temkin Discusses Biosimilar Approvals at ACI," AJMC The Center for Biosimilars, September 23, 2020

"Genentech Defends Herceptin Dosing Patents Before PTAB," Law360, May 8, 2018

"PTAB Reverses Course, Institutes Review Of Herceptin Patent," Law360, October 30, 2017

"WL Gore Can't Recover Lost Profits In Stent IP Row: Judge," Law360, July 29, 2016

“The 2016 IP Hot List: Kirkland & Ellis,” The National Law Journal, June 6, 2016

“Texas Company Beats Microsoft at the 'Death Squad,’ ” Texas Lawyer, March 28, 2016

"Kirkland & Ellis," The National Law Journal, February 29, 2016

"2015 Practice Group of the Year: Intellectual Property," Law360, February 1, 2016

"Microsoft Corporation v. Biscotti Inc.: Decision Denying Request for Rehearing IPR2014-01457," The National Law Review, July 5, 2015

"Judge Issues Rare Injunction In CR Bard Unit's Patent Case," Law360, March 11, 2015

Seminars

Presenter, along with Pfizer’s Global Biosimilars Lead and Sandoz’s Executive Director, Scientific Affairs: Biosimilars Virtual Conference, The Challenges & Opportunities for Biosimilars in the US

Presenter, along with Fresenius Medical Care’s Vice President, Associate General Counsel, Global Intellectual Property, GSK’s Vice President, Global Patent Litigation Governance, Head of Patents, and Bayer’s Senior Counsel: LESI 2018 Annual Conference, Doing Major Life Sciences Deals: The Keys To Success

Speaker at Practicing Law Institute Conference: Litigation Issues in Intellectual Property Licensing

Recognition

Recognized for "500 Leading Litigators in America," by Lawdragon, 2024

Recognized for Intellectual Property by Chambers USA, 2021–2024

Recognized for Patent Litigation: Full Coverage [Next Generation, 2020] by The Legal 500 U.S., 2017–2022

Recommended in IAM Patent 1000, 2020–2023

Shortlisted for Life Sciences in Euromoney Legal Media Group's Americas Rising Star Awards, 2019

Recognized for Intellectual Property in the “Top Attorneys Under 40” list of Law360, 2018

Nominated in the "Women of Influence" list of Best Lawyers, 2017

Recognized in the "Under 40 Hotlist" of Benchmark Litigation, 2016–2019

Credentials

Admissions & Qualifications

  • 2003, Illinois
  • Registered to practice before the United States Patent and Trademark Office

Courts

  • Supreme Court of Illinois
  • United States District Court for the Northern District of Illinois
  • United States District Court for the Southern District of Illinois
  • United States District Court for the District of Delaware
  • United States District Court for the Eastern District of Texas
  • United States District Court for the Northern District of Ohio
  • United States District Court for the Southern District of Ohio
  • United States District Court for the District of Maryland
  • United States Court of Appeals for the Federal Circuit
  • United States Court of Appeals for the Seventh Circuit
  • United States International Trade Commission
  • United States Patent and Trademark Office, Patent Trial and Appeal Board

Education

  • University of North Carolina School of LawJ.D.with Honors2003

    Editor, North Carolina Law Review

    Gressman-Pollitt Award for Outstanding Oral Advocacy

  • University of Illinois at Urbana-ChampaignB.S., Biologycum laude2000

    Minor in Chemistry 

    Member, Phi Beta Kappa Honor Society

    James Scholar

    Cross-country, Track